The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition
- PMID: 15899888
- DOI: 10.1074/jbc.M501931200
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition
Abstract
The liver plays a central role in the control of blood glucose homeostasis by maintaining a balance between glucose production and utilization. The farnesoid X receptor (FXR) is a bile acid-activated nuclear receptor. Hepatic FXR expression is regulated by glucose and insulin. Here we identify a role for FXR in the control of hepatic carbohydrate metabolism. When submitted to a controlled fasting-refeeding schedule, FXR(-/-) mice displayed an accelerated response to high carbohydrate refeeding with an accelerated induction of glycolytic and lipogenic genes and a more pronounced repression of gluconeogenic genes. Plasma insulin and glucose levels were lower in FXR(-/-) mice upon refeeding the high-carbohydrate diet. These alterations were paralleled by decreased hepatic glycogen content. Hepatic insulin sensitivity was unchanged in FXR(-/-) mice. Treatment of isolated primary hepatocytes with a synthetic FXR agonist attenuated glucose-induced mRNA expression as well as promoter activity of L-type pyruvate kinase, acetyl-CoA carboxylase 1, and Spot14. Moreover, activated FXR interfered negatively with the carbohydrate response elements regions. These results identify a novel role for FXR as a modulator of hepatic carbohydrate metabolism.
Similar articles
-
The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.J Hepatol. 2018 Nov;69(5):1099-1109. doi: 10.1016/j.jhep.2018.06.022. Epub 2018 Jul 5. J Hepatol. 2018. PMID: 29981427
-
Transient impairment of the adaptive response to fasting in FXR-deficient mice.FEBS Lett. 2005 Aug 1;579(19):4076-80. doi: 10.1016/j.febslet.2005.06.033. FEBS Lett. 2005. PMID: 16023103
-
Regulation of carbohydrate metabolism by the farnesoid X receptor.Endocrinology. 2005 Mar;146(3):984-91. doi: 10.1210/en.2004-0965. Epub 2004 Nov 24. Endocrinology. 2005. PMID: 15564327
-
Role of bile acids and bile acid receptors in metabolic regulation.Physiol Rev. 2009 Jan;89(1):147-91. doi: 10.1152/physrev.00010.2008. Physiol Rev. 2009. PMID: 19126757 Review.
-
Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.Biochimie. 2005 Jan;87(1):93-8. doi: 10.1016/j.biochi.2004.11.018. Biochimie. 2005. PMID: 15733743 Review.
Cited by
-
Lipid and energy metabolism in Wilson disease.Liver Res. 2020 Mar;4(1):5-14. doi: 10.1016/j.livres.2020.02.002. Epub 2020 Feb 19. Liver Res. 2020. PMID: 32832193 Free PMC article.
-
Reduced glycodeoxycholic acid levels are associated with negative clinical outcomes of gestational diabetes mellitus.J Zhejiang Univ Sci B. 2021 Mar 15;22(3):223-232. doi: 10.1631/jzus.B2000483. J Zhejiang Univ Sci B. 2021. PMID: 33719227 Free PMC article.
-
Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.Mol Cell Biol. 2013 Jun;33(11):2202-11. doi: 10.1128/MCB.01004-12. Epub 2013 Mar 25. Mol Cell Biol. 2013. PMID: 23530060 Free PMC article.
-
Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial.Eur J Endocrinol. 2013 Apr 15;168(5):771-8. doi: 10.1530/EJE-12-0969. Print 2013 May. Eur J Endocrinol. 2013. PMID: 23447519 Free PMC article. Clinical Trial.
-
Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.Pharm Res. 2013 May;30(5):1447-57. doi: 10.1007/s11095-013-0986-7. Epub 2013 Feb 1. Pharm Res. 2013. PMID: 23371517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
